While studies have demonstrated the involvement of growth factors like TGF-β1 in the immune-mediated inflammation and fibrosis observed in Sjogren syndrome, indicating their role in the disease’s progression rather than its initiation,[32,33] other research suggests that these factors may not trigger the initial disease onset. This evidence concerns the gene TGFB1 and Sjogren syndrome.